Phosphodiesterase inhibitors: the inotropes of choice for the new millennium?

Editorial

J H Levy et al. J Cardiothorac Vasc Anesth. 2000 Aug.

. 2000 Aug;14(4):365-6.

doi: 10.1053/jcan.2000.7919.

No abstract available

Comment on

Hemodynamic effects of milrinone during weaning from cardiopulmonary bypass: comparison of patients with a low and high prebypass cardiac index.
Yamada T, Takeda J, Katori N, Tsuzaki K, Ochiai R. Yamada T, et al. J Cardiothorac Vasc Anesth. 2000 Aug;14(4):367-73. doi: 10.1053/jcan.2000.7920. J Cardiothorac Vasc Anesth. 2000. PMID: 10972598 Clinical Trial.
Milrinone, not epinephrine, improves left ventricular compliance after cardiopulmonary bypass.
Lobato EB, Gravenstein N, Martin TD. Lobato EB, et al. J Cardiothorac Vasc Anesth. 2000 Aug;14(4):374-7. doi: 10.1053/jcan.2000.7921. J Cardiothorac Vasc Anesth. 2000. PMID: 10972599 Clinical Trial.
Pharmacokinetics of amrinone in neonates and infants.
Laitinen P, Ahonen J, Olkkola KT, Peltola K, Rautiainen P, Räsänen J. Laitinen P, et al. J Cardiothorac Vasc Anesth. 2000 Aug;14(4):378-82. doi: 10.1053/jcan.2000.7922. J Cardiothorac Vasc Anesth. 2000. PMID: 10972600